AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,815 Cr | ₹2,575 Cr | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr |
What is the latest Total Liabilities ratio of AARTI DRUGS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹2,815 Cr |
| Mar2025 | ₹2,575 Cr |
| Mar2024 | ₹2,432 Cr |
| Mar2023 | ₹2,421 Cr |
| Mar2022 | ₹2,208 Cr |
How is Total Liabilities of AARTI DRUGS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,815 Cr | 9.34 | |
| Mar2025 | ₹2,575 Cr | 5.85 | |
| Mar2024 | ₹2,432 Cr | 0.45 | |
| Mar2023 | ₹2,421 Cr | 9.67 | |
| Mar2022 | ₹2,208 Cr | - | |
Compare Total Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,747.0 Cr | -3.3% | -2.4% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -3.3% |
-2.4% |
-17.2% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses